☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
KRASG12C-Mutant NSCLC
Mirati Signs a Non-Exclusive Clinical Collaboration Agreement with Verastem to Evaluate Adagrasib + VS-6766 for KRASG12C-Mutant NS...
November 23, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.